Clinical Trial Update: Radiotherapy to All Residual Lesions After Chemoimmunotherapy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating radiotherapy to all residual lesions after chemoimmunotherapy in extensive-stage small cell lung cancer, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING